Clinical efficacy of pentoxifylline, tocopherol, and clodronate therapy
Originally at sciencedirect.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Oral surgeons and oncologists managing post-radiation patients may encounter a new evidence summary on pentoxifylline-tocopherol-clodronate for osteoradionecrosis; owners of practices treating head-and-neck cancer referrals should monitor whether this changes local protocols.
Key points
- Systematic review and meta-analysis covers pentoxifylline, tocopherol, and clodronate therapy for osteoradionecrosis.
- Article appears in the Journal of Oral & Maxillofacial Surgery and lists Dr Matthew Woliansky, Cheryl Chen, and Dr James Badlani as authors.
- Content became available online 19 October 2026.
Who should care
Read the original on Journal of Oral & Maxillofacial Surgery (JOMS)
Full reporting and any paywall content live on sciencedirect.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Prosthodontist accused of running drug ‘party house’
- ·Research
Masseter muscle volume and cross-sectional area as risk factors
- ·Research
The association between parafunctional oral habits
- ·Regulatory
Groups propose legislation allowing West Virginia dentists, hygienists to administer HPV vaccine